Dormico Latashia Walker, NP
Psychiatric/Mental Health · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 2 carriers
- Office
- 1
Offices
1 location
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dormico Latashia Walker’s office at (323) 745-8323 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
Medicaid work
$95,848 in 2024
Medicaid paid $95,848 for 1,195 billed services this clinician did in 2024, up to 85 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 452 | $33,067 |
| Return visit (30+ min) | 364 | $29,355 |
| Psychiatric diagnostic evaluation with medical services | 108 | $22,442 |
| Short return visit (20+ min) | 229 | $10,983 |
| TOBACCO NON-USER | 27 | $0 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 15 | $0 |
| 2024 | 1,195 | 6 | 85 | $95,848 |
| 2023 | 2,823 | 5 | 119 | $215,389 |
| 2022 | 2,091 | 6 | 132 | $157,945 |
| 2021 | 2,231 | 7 | 113 | $165,652 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 1,257 | $94,646 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 868 | $61,979 |
| Psychiatric diagnostic evaluation with medical services | 249 | $46,694 |
| Short return visit (20+ min) | 284 | $12,070 |
| TOBACCO NON-USER | 165 | $0 |
2022
| Return visit (30+ min) | 1,307 | $96,375 |
| Psychiatric diagnostic evaluation with medical services | 199 | $40,145 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 318 | $19,513 |
| Case management, each 15 minutes | 69 | $1,075 |
| Short return visit (20+ min) | 19 | $836 |
| TOBACCO NON-USER | 179 | $1 |
2021
| Return visit (30+ min) | 942 | $66,871 |
| Psychiatric diagnostic evaluation with medical services | 282 | $48,581 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 746 | $44,341 |
| Short return visit (20+ min) | 101 | $5,018 |
| Short return visit | 23 | $651 |
| Case management, each 15 minutes | 15 | $191 |
| TOBACCO NON-USER | 122 | $0 |
Drugs they prescribed that Part D paid
$11,806
Pharmacies billed $11,806 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 307) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
300 generic and fewer than 11 brand-name prescriptions · $11,806 in drug cost · 11 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Aripiprazole | 24 | $722 | $30 |
| Quetiapine | 25 | $669 | $27 |
| Olanzapine | 19 | $477 | $25 |
| Dextroamphetamine-Amphet Er | 11 | $429 | $39 |
| Gabapentin | 14 | $205 | $15 |
See all 10 drugs
| Aripiprazole | 24 | $722 | $30 |
| Quetiapine | 25 | $669 | $27 |
| Olanzapine | 19 | $477 | $25 |
| Dextroamphetamine-Amphet Er | 11 | $429 | $39 |
| Gabapentin | 14 | $205 | $15 |
| Sertraline | 31 | $139 | $4 |
| Trazodone | 15 | $134 | $9 |
| Clonazepam | 13 | $120 | $9 |
| Lamotrigine | 19 | $87 | $5 |
| Alprazolam | 12 | $78 | $6 |
Year by year
| 2024 | 307 | 37 | 0% (0) | None | $11,806 |
| 2023 | 1,502 | 109 | 0% (0) | 6% | $280,827 |
| 2022 | 688 | 94 | 0% (0) | 3% | $83,661 |
| 2021 | 296 | 54 | 0% (0) | 5% | $29,211 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 39 drugs
| Ingrezza | 15 | $127,378 | $8,492 |
| Vyvanse | 13 | $5,045 | $388 |
| Aripiprazole | 47 | $4,578 | $97 |
| Trazodone | 88 | $2,582 | $29 |
| Olanzapine | 94 | $2,220 | $24 |
| Prazosin | 28 | $2,133 | $76 |
| Risperidone | 92 | $2,003 | $22 |
| Quetiapine | 53 | $1,931 | $36 |
| Oxcarbazepine | 28 | $1,660 | $59 |
| Divalproex Sodium Er | 33 | $1,559 | $47 |
| Hydroxyzine | 33 | $1,557 | $47 |
| Dextroamphetamine-Amphet Er | 18 | $1,537 | $85 |
| Ramelteon | 12 | $1,363 | $114 |
| Ziprasidone | 15 | $1,263 | $84 |
| Haloperidol | 29 | $1,239 | $43 |
| Duloxetine | 44 | $1,195 | $27 |
| Gabapentin | 50 | $1,179 | $24 |
| Sertraline | 93 | $1,082 | $12 |
| Bupropion Xl | 27 | $969 | $36 |
| Venlafaxine Hcl Er | 27 | $928 | $34 |
| Citalopram Hbr | 46 | $894 | $19 |
| Buspirone | 25 | $823 | $33 |
| Mirtazapine | 28 | $823 | $29 |
| Benztropine Mesylate | 52 | $775 | $15 |
| Escitalopram | 52 | $757 | $15 |
| Clonazepam | 63 | $546 | $9 |
| Lamotrigine | 36 | $520 | $14 |
| Fluoxetine | 33 | $451 | $14 |
| Doxepin | 11 | $385 | $35 |
| Bupropion Hcl Sr | 21 | $357 | $17 |
| Dextroamphetamine-Amphetamine | 14 | $295 | $21 |
| Bupropion | 12 | $289 | $24 |
| Clonidine | 20 | $250 | $13 |
| Diazepam | 26 | $192 | $7 |
| Alprazolam | 15 | $186 | $12 |
| Divalproex | 12 | $173 | $14 |
| Hydroxyzine Pamoate | 13 | $139 | $11 |
| Lithium Carbonate | 12 | $130 | $11 |
| Lorazepam | 16 | $86 | $5 |
2022: 22 drugs
| Fluoxetine | 35 | $2,766 | $79 |
| Aripiprazole | 54 | $2,113 | $39 |
| Venlafaxine Hcl Er | 22 | $957 | $44 |
| Mirtazapine | 11 | $826 | $75 |
| Duloxetine | 23 | $729 | $32 |
| Divalproex Sodium Er | 12 | $725 | $60 |
| Prazosin | 11 | $701 | $64 |
| Olanzapine | 31 | $570 | $18 |
| Trazodone | 45 | $533 | $12 |
| Quetiapine | 38 | $488 | $13 |
| Sertraline | 37 | $464 | $13 |
| Dextroamphetamine-Amphetamine | 14 | $362 | $26 |
| Clonidine | 14 | $359 | $26 |
| Lamotrigine | 28 | $349 | $12 |
| Clonazepam | 39 | $338 | $9 |
| Risperidone | 28 | $333 | $12 |
| Hydroxyzine Pamoate | 23 | $285 | $12 |
| Escitalopram | 23 | $276 | $12 |
| Bupropion Hcl Sr | 14 | $270 | $19 |
| Temazepam | 14 | $219 | $16 |
| Gabapentin | 18 | $195 | $11 |
| Lorazepam | 11 | $51 | $5 |
2021: 8 drugs
| Fluoxetine | 31 | $897 | $29 |
| Aripiprazole | 24 | $449 | $19 |
| Quetiapine | 13 | $344 | $26 |
| Clonidine | 15 | $298 | $20 |
| Trazodone | 21 | $296 | $14 |
| Duloxetine | 13 | $239 | $18 |
| Escitalopram | 14 | $80 | $6 |
| Clonazepam | 14 | $63 | $4 |
Money from drug and device companies
$150 in 2023
| 2023 | 2 | 2 | None | $150 |
| 2022 | 8 | 21 | None | $754 |
| 2021 | 4 | 14 | None | $448 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Corium | Azstarys | $125 | 1 payment
|
| Boston Scientific | None | $25 | 1 payment
|
See all 2 published payments
| Boston Scientific | Meals · 2023-08-22 | None | $25 |
| Corium | Meals · 2023-06-08 | Azstarys | $125 |
See earlier years (2022, 2021)
2022: $754
| Abbvie | Vraylar | $242 | 3 payments
|
| Alkermes | Lybalvi | $160 | 4 payments
|
| Neurocrine Biosciences | Ingrezza | $141 | 3 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $118 | 6 payments
|
| Teva Pharmaceuticals USA | Austedo | $38 | 2 payments
|
| Iti | Caplyta | $22 | 1 payment
|
| Otsuka America Pharmaceutical | Rexulti | $20 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $12 | 1 payment
|
2021: $448
| Alkermes | Lybalvi | $236 | 6 payments
|
| Sunovion Pharmaceuticals | Latuda | $102 | 6 payments
|
| Iti | Caplyta | $91 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $19 | 1 payment
|
Professional record
- NPI
- 1841892593
- Licence
- AZ CNP-249922, AZ RN202021
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X); Federal specialty code 163WP0807X (163WP0807X); Federal specialty code 163WP0808X (163WP0808X)
- Mailing address
- 4633 Old Ironsides Dr Ste 304, Santa Clara, CA, 95054
- NPI first listed
- 2020-11-09
- NPI last updated
- 2026-05-03
- NPI record certified
- 2026-05-03
This is when the NPI record was last certified, not a medical board exam.